Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Dec 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether a special imaging technique using a dye called indocyanine green, either alone or with additional fluorescence, can help surgeons locate and preserve parathyroid glands during thyroid and parathyroid surgery. The parathyroid glands are small glands that help control important body functions, and safely identifying them during surgery is crucial to prevent complications.
To participate in this study, you need to be at least 18 years old and able to undergo surgery. However, if you have allergies to iodine, shellfish, or indocyanine green, or if you are pregnant, you won't be eligible to join. If you do take part, you can expect to have your surgery with this new imaging technique, which aims to make the procedure safer and more effective. The trial is currently recruiting participants of all genders and ages above 18.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age greater than 18 years old
- Exclusion Criteria:
- • Patients with iodine or shellfish allergies would be excluded.
- • Patients with allergy to indocyanine green.
- • Pregnancy
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Herbert Chen, MD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported